HSIC vs TECH: fair value comparison
Henry Schein, Inc. and Bio-Techne Corporation · Updated 2026-10-19
HSIC currently screens as fairly valued while TECH screens as undervalued. Within Healthcare, TECH currently sits closer to the top of our ranking by discount to fair value. TECH carries the stronger quality grade.
| HSIC | TECH | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $84.01 | $72.46 |
| 12-month range | $62.32–$90.86 | $43.30–$72.61 |
| Rank by discount to fair value | #47 of 108 Healthcare | #42 of 108 Healthcare |
| Quality grade | F | A |
| Leverage | Moderate | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HSIC fair value analysis · TECH fair value analysis